Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents

Diagnostic Microbiology and Infectious Disease - Tập 15 - Trang 435-439 - 1992
Lawrence J. Eron1, Layne O. Gentry2
1From the Fairfax Hospital, Falls Church, Virginia, and Georgetown University School of Medicine, Washington, DC, USA
2Infectious Diseases Section, St. Luke's Episcopal Hospital, and Department of Medicine, Microbiology, and Immunology, Baylor College of Medicine, Houston, Texas, USA

Tài liệu tham khảo

Gentry, 1989, A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections, Am J Med, 87, S57

Chidiac, 1989, Efficacy and safety of oral ofloxacin for treatment of pneumonia, Rev Infect Dis, 11, S1223

Forsberg, 1989, Comparative study of oral ofloxacin and erythromycin in the treatment of pneumonia, Rev Infect Dis, 11, S1229

Gentry, 1991, Ofloxacin versus parenteral therapy for chronic osteomyelitis, Antimicrob Agents Chemother, 35, 538, 10.1128/AAC.35.3.538

King, 1986, The comparative in-vitro activity of eight newer quinolones and nalidixic acid, J Antimicrob Chemother, 18, 1

Pharmaceutical Manufacturers Association (PMA), 1988

Chow, 1989, Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations, Antimicrob Agents Chemother, 33, 1368, 10.1128/AAC.33.8.1368

Thông tin
Thông tin xuất bản

Diagnostic Microbiology and Infectious Disease

Tập 15

435-439

Thông tin tác giả